{
    "clinical_study": {
        "@rank": "97362", 
        "arm_group": [
            {
                "arm_group_label": "Individual psychoeducation", 
                "arm_group_type": "Experimental", 
                "description": "Usual treatment + individual psychoeducational intervention (14 sessions). The psychoeducational programme consists of 14 sessions of 60 minutes every other week for six months, focused on improving patient awareness of their condition, adherence to treatment, identification of prodromes, early intervention in potential relapses, anxiety management techniques, social skills, healthy lifestyle habits and problem solving."
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Active Comparator", 
                "description": "Usual treatment"
            }
        ], 
        "brief_summary": {
            "textblock": "Treatment delay in psychosis usually lead to slower recovery, an increase in associated\n      comorbidity and greater deterioration in social and family life of patients. Previous\n      studies indicate that an early intervention with guidelines for increasing adherence to\n      treatment, disease awareness and condition management leads to better progression of the\n      disorder and is therefore related to a better prognosis.\n\n      Several studies have found that the rate of relapse is higher in patients with\n      pharmacological treatment alone compared to those also receiving psychoeducation, who tend\n      to improve their adherence to treatment and reduce toxic drugs dosage.\n\n      Hypotheses:\n\n        -  Individual psychoeducation will be effective as complementary therapy to\n           pharmacological treatment in patients with a first psychotic episode, improving disease\n           evolution.\n\n        -  BDNF levels will increase more in the patients receiving individual therapy compared to\n           those without it.\n\n        -  Psychoeducation can be performed similarly in all participating centers if the\n           therapists receive the same training and use the same psychoeducation material.\n\n        -  The use of telemedicine for the follow-up of the patients will help improve the welfare\n           work and therefore the disease evolution."
        }, 
        "brief_title": "e-Learning & Development of an Evidence-based Psychoeducational Programme for First Episode Psychosis", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Psychosis", 
        "condition_browse": {
            "mesh_term": [
                "Mental Disorders", 
                "Psychotic Disorders"
            ]
        }, 
        "detailed_description": {
            "textblock": "Treatment delay in psychosis usually lead to slower recovery, an increase in associated\n      comorbidity and greater deterioration in social and family life of patients. Previous\n      studies indicate that an early intervention with guidelines for increasing adherence to\n      treatment, disease awareness and condition management leads to better progression of the\n      disorder and is therefore related to a better prognosis.\n\n      Several studies have found that the rate of relapse is higher in patients with\n      pharmacological treatment alone compared to those also receiving psychoeducation, who tend\n      to improve their adherence to treatment and reduce toxic drugs dosage.\n\n      Hypotheses:\n\n        -  Individual psychoeducation will be effective as complementary therapy to\n           pharmacological treatment in patients with a first psychotic episode, improving the\n           disease evolution.\n\n        -  BDNF levels will increase more in the patients receiving individual therapy compared to\n           those without it.\n\n        -  Psychoeducation can be performed similarly in all participating centers if the\n           therapists receive the same training and use the same psychoeducation material.\n\n        -  The use of telemedicine for the follow-up of the patients will help improve the welfare\n           work and therefore the disease evolution.\n\n      Primary  Objective:\n\n        -  To assess the effectiveness of individual psychoeducation together with telemedicine\n           (telephone assistance) as an adjuvant therapy in the pharmacological treatment of\n           patients with first episode psychosis, regarding functionality of patients and positive\n           and negative symptoms.\n\n      Secondary Objectives:\n\n        -  To analyse certain biological parameters (BDNF and oxidative stress) in both arms\n           (intervention and control) at baseline and during re-assessment (at six months and\n           after completion of treatment).\n\n        -  To analyse the effectiveness of online training of psychotherapists who will provide\n           psychoeducation to patients with first episode psychosis."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients who have suffered a first psychotic episode (diagnosis IV-TR) in the last\n             five years,\n\n          -  age between 18 and 45 years,\n\n          -  patients who have given written informed consent to participate.\n\n        Exclusion Criteria:\n\n          -  patients with a comorbid disorder that interferes with their ability to communicate,\n\n          -  patients who received psychoeducation previous to inclusion in study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "260", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01783457", 
            "org_study_id": "PsychEd-FEP"
        }, 
        "intervention": [
            {
                "arm_group_label": "Control", 
                "description": "Usual treatment: pharmacological treatment + regular sessions with their psychiatrist.", 
                "intervention_name": "Control", 
                "intervention_type": "Other", 
                "other_name": "Usual treatment"
            }, 
            {
                "arm_group_label": "Individual psychoeducation", 
                "description": "Usual treatment + individual psychoeducational programme, consisting of 14 sessions of 60 minutes every other week for six months, focused on improving patient awareness of their condition, adherence to treatment, identification of prodromes, early intervention in potential relapses, anxiety management techniques, social skills, healthy lifestyle habits and problem solving.\nProgramme of sessions available upon request.", 
                "intervention_name": "Individual psychoeducation", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "First psychotic episode", 
            "Individual psychoeducation", 
            "Telemedicine", 
            "BDNF", 
            "Oxidative stress"
        ], 
        "lastchanged_date": "February 1, 2013", 
        "location": [
            {
                "contact": {
                    "email": "jmcrespo@bellvitgehospital.cat", 
                    "last_name": "Jose Manuel Crespo"
                }, 
                "facility": {
                    "address": {
                        "city": "Hospitalet Llobregat", 
                        "country": "Spain", 
                        "state": "Barcelona", 
                        "zip": "08907"
                    }, 
                    "name": "Hospital Universitario de Bellvitge"
                }, 
                "investigator": {
                    "last_name": "Jose Manuel Crespo", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bilbao", 
                        "country": "Spain", 
                        "state": "Vizcaya", 
                        "zip": "48940"
                    }, 
                    "name": "Universidad del Pa\u00eds Vasco"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "FCOLOM@clinic.ub.es", 
                    "last_name": "Francesc Colom"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08036"
                    }, 
                    "name": "Hospital Clinic de Barcelona"
                }, 
                "investigator": {
                    "last_name": "Francesc Colom", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "esterlorente@hotmail.com", 
                    "last_name": "Ester Lorente"
                }, 
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain", 
                        "zip": "46010"
                    }, 
                    "name": "Fundaci\u00f3n Cl\u00ednico Valencia INCLIVA"
                }, 
                "investigator": {
                    "last_name": "Ester Lorente", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Vicente.Balanza@uv.es", 
                    "last_name": "Vicent Balanz\u00e1"
                }, 
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain", 
                        "zip": "46010"
                    }, 
                    "name": "Universidad de Valencia"
                }, 
                "investigator": {
                    "last_name": "Vicent Balanz\u00e1", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "ANAMARIA.GONZALEZ-PINTOARRILLAGA@osakidetza.net", 
                    "last_name": "Ana Mar\u00eda Gonz\u00e1lez-Pinto, Psychiatrist", 
                    "phone": "+34 945 007617"
                }, 
                "contact_backup": {
                    "email": "PATRICIA.VEGAPEREZ@osakidetza.net", 
                    "last_name": "Patricia Vega, Psychologist", 
                    "phone": "+34 945 007617"
                }, 
                "facility": {
                    "address": {
                        "city": "Vitoria", 
                        "country": "Spain", 
                        "state": "\u00c1lava", 
                        "zip": "01004"
                    }, 
                    "name": "Araba University Hospital-Santiago"
                }, 
                "investigator": {
                    "last_name": "Ana Mar\u00eda Gonz\u00e1lez-Pinto, Psychiatrist", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "e-Learning & Development of an Evidence-based Psychoeducational Programme for First Episode Psychosis", 
        "overall_contact": {
            "email": "ANAMARIA.GONZALEZ-PINTOARRILLAGA@osakidetza.net", 
            "last_name": "Ana Mar\u00eda Gonz\u00e1lez-Pinto, Psychiatrist", 
            "phone": "+34 945 007617"
        }, 
        "overall_official": {
            "affiliation": "Santiago Hospital - Basque Health Service", 
            "last_name": "Patricia Vega, Psychologist", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To assess the prognosis of patients by registering the number of relapses and the number of psychiatric hospital admissions.", 
            "measure": "Prognosis of patients.", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01783457"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Basque Health Service", 
            "investigator_full_name": "Ana Mar\u00eda Gonz\u00e1lez-Pinto", 
            "investigator_title": "Ph.D. in Medicine, Psychiatrist, Lecturer at University of the Basque Country, Chief of Psychiatry Department at Araba University Hospital", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "To assess the effectiveness of individual psychoeducation together with telemedicine (telephone assistance) as an adjuvant therapy in the pharmacological treatment of patients with first episode psychosis, using different scales for clinical assessment of FUNCTIONALITY (Positive and Negative Syndrome Scale (PANSS), SUMD, Morisky-Green Scale, STAI, Hamilton Rating scale for Depression, LSAS, WHOQOL-BREF, EuroQoL) and PROGNOSIS (Strauss Carpenter Scale, GAF, Functional Assessment Staging Test-FAST).", 
                "measure": "Score on clinical scales assessing functionality.", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "To analyse the effectiveness of online training of psychotherapist who will provide psychoeducation to patients, all therapists carried out a specific tests after each one of the sessions to confirm if they had delivered the session as specified in the protocol.", 
                "measure": "Score of participating psychotherapists on a specific test after online training.", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "To analyse BDNF biological parameter at baseline and during re-assessment at six months (after completion of treatment): BDNF levels in plasma will be measured by ELISA techniques with a kit based on the Sandwich technique used according to the manufacturer\u00b4s instructions (CYT306 from Chemicon). The standard curves will be characterised using plasma duplicates and the absorption determined with a microplate reader (BIO-TEK, Sinergy HT) using a wavelength of 450 nm.", 
                "measure": "Biological Parameters: blood levels of BDNF.", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "To analyse OXIDATIVE STRESS indicators at baseline and during re-assessment at six months (after completion of treatment): Levels of the following OXIDATIVE STRESS INDICATORS will be measured in red blood cell haemolysates: lipid peroxidation (TBARS), nitrites and superoxide dismutase enzyme, total antioxidant ability, glutathione peroxidase and catalase.", 
                "measure": "Biological Parameters: levels oxidative stress indicators in blood.", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "Basque Health Service", 
        "sponsors": {
            "collaborator": {
                "agency": "Carlos III Health Institute", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Basque Health Service", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}